Skip to main content
Premium Trial:

Request an Annual Quote

Spotfire, Applied Biosystems Ink Gene Expression Technology Deal

NEW YORK, June 28 (GenomeWeb News) - Spotfire announced today that it has signed a deal with Applied Biosystems under which the companies will combines certain of their technologies for human gene expression research.

 

Under the deal, Applied Biosystems will build analysis capabilities on top of Spotfire's DecisionSite platform, and offer with its newly released Expression Array system 90-day evaluation licenses of the Spotfire's DecisionSite for Function Genomics software.

 

"We are pleased to be aligned with Applied Biosystems as it expands its footprint in the gene expression analysis market with the introduction of the Expression Array System," Christopher Ahlberg, CEO of Spotfire, said in a statement. "By combining these technologies, researchers engaged in microarray analysis will be able to conduct more comprehensive analysis in less time."

 

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.